Publications

  1. van Nagell, J.R., Jr.; Tweeddale, D.N.; and Roddick, J.W., Jr.:  Primary Adenoacanthoma of the Bartholin Gland.  Obstet. Gynecol. 34:87, 1969.
  2. van Nagell, J.R., Jr.; Koepke, J.; and Dilts, P.V., Jr.:  Preventable Anemia and Pregnancy.  Obstet. Gynecol.  Survey 26:551, 1971.
  3. van Nagell, J.R., Jr.; Roddick, J.W., Jr.; and Lowin, D.M.:  The Staging of Cervical Cancer:  Inevitable Discrepancies Between Clinical Staging and Pathologic Findings.  Am. J. Obstet. Gynecol. 110:973, 1971.
  4. van Nagell, J.R., Jr. and Roddick, J.W., Jr.:  Vaginal Hysterectomy as a Sterilization Procedure.  Am. J. Obstet. Gynecol. 111:703, 1972.
  5. van Nagell, J.R., Jr. and Roddick, J.W.:  Vaginal Hysterectomy, The Ureter, and Excretory Urography.  Obstet. Gynecol. 39:784, 1972.
  6. Thelin, J.T. and van Nagell, J.R., Jr.:  Ruptured Ectopic Pregnancy After Bilateral Tubal Ligation.  Obstet. Gynecol. 39:589, 1972.
  7. van Nagell, J.R., Jr.; Penny, R.; and Roddick, J.W., Jr.:  Suprapubic Bladder Drainage Following Radical Hysterectomy.  Am. J. Obstet. Gynecol. 113:849, 1972.
  8. van Nagell, J.R., Jr.; Wallace, J.O.; and Roddick, J.W., Jr.:  Clinical Correlates of Endometrial Carcinoma.  Am. J. Obstet. Gynecol. 112:935, 1972.
  9. van Nagell, J.R., Jr.; Roddick, J.W., Jr.; Cooper, R.W.; and Triplett, B.:  Vaginal Hysterectomy Following Conization in the Treatment of Carcinoma-in-Situ of the Cervix.  Am. J. Obstet. Gynecol. 113:948, 1972.
  10. van Nagell, J.R., Jr.; Harralson, J.D.; and Roddick, J.W., Jr.:  The Effect of Examination Under Anesthesia on Staging Accuracy in Cervical Cancer.  Am. J. Obstet. Gynecol. 113:938, 1972.
  11. Harralson, J.D. and van Nagell, J.R., Jr.:  Operative Management of Ruptured Tubal Pregnancy.  Am. J. Obstet. Gynecol. 115:995, 1973.
  12. Spurlin, G.W.; van Nagell, J.R., Jr.; Roddick, J.W., Jr.; and Parker, J.C., Jr.:  Uterine Myomas and Erthrocytosis.  Obstet. Gynecol. 40:646, 1972.
  13. van Nagell, J.R., Jr.; Hager, W.D.; and Roddick, J.W., Jr.:  Reliability of the Cervical Cytologic Smear as a Screening Procedure in Patients Undergoing Gynecologic Surgery for Benign Disease.  Am. J. Obstet. Gynecol. 116:111, 1973.
  14. Parker, J.C., Jr.; van Nagell, J.R., Jr.; and Harralson, J.D.:  The Mesonephroid (Hypernephroid) Carcinomatous Pattern - A Rare Variant of Primary Endocervical Adenocarcinoma.  Cancer 32:259, 1973.
  15. Wilson, E.A.; Sprague, A.D.; and van Nagell, J.R., Jr.; Suprapubic Cystostomy in Gynecologic Surgery:  A Comparison of Two Methods.  Am. J. Obstet. Gynecol. 115:991, 1973.
  16. Roddick, J.W., Jr.; van Nagell, J.R., Jr.; and Bell, R.M.:  Protein and Electrolyte Concentration of Retroperitoneal Drainage Following Radical Hysterectomy with Pelvic Lymphadenectomy.  Gyn. Oncol. 1:149, 1973.
  17. van Nagell, J.R., Jr.; Maruyama, Y.; Parker, J.C., Jr.; and Dalton, W.L.:  Small Bowel Injury Following Radiation Therapy for Cervical Cancer.  Am. J. Obstet. Gynecol. 118:163, 1974.
  18. Sprague, A.D. and van Nagell, J.R., Jr.:  The Relationship of Age and Endometrial Histology to Blood Loss and Morbidity Following Vaginal Hysterectomy.  Am. J. Obstet. Gynecol. 118:805, 1974.
  19. Maruyama, Y.; Hoskins, B.; Wrede, D.E.; Sowell, G.; and van Nagell, J.R., Jr.:  Probe Check of Computer Dosimetry for Gynecological Implant Therapy.  Acta. Radiologica. 13:49, 1974.
  20. van Nagell, J.R., Jr.; Parker, J.C., Jr.; Maruyama, Y.; Utley, J.; and Luckett, P.:  Bladder and Rectal Injury Following Radiation Therapy for Cervical Cancer.  Am. J. Obstet. Gynecol. 119:727, 1974.
  21. Pletsch, Q.A.; van Nagell, J.R., Jr.; and Goldenberg, D.M.:  Characterization of Carcinoembryonic Antigen in the Plasma and Tumors of Patients with Ovarian Cancer.  Proc. Am. Assoc. Cancer Res. 15:146, 1974.
  22. Harralson, J.D.; van Nagell, J.R., Jr.; Roddick, J.W., Jr.; and Sprague, A.D.:  The Effect of Prophylactic Antibiotics on Pelvic Infection Following Vaginal Hysterectomy.  Am. J. Obstet. Gynecol. 120:1046, 1974.
  23. Maruyama, Y.; van Nagell, J.R., Jr.; Utley, J.; Vider, M.L.; and Parker, J.C., Jr.:  Radiation and Small Bowel Complications in Cervical Carcinoma Therapy.  Radiol. 112:699, 1974.
  24. van Nagell, J.R., Jr.; Meeker, W.R.; Parker, J.C., Jr.; and Harralson, J.D.:  Carcinoembryonic Antigen in Patients with Gynecologic Malignancy.  Cancer 35:1372, 1975.
  25. van Nagell, J.R., Jr.; Sprague, A.D.; and Roddick, J.W., Jr.:  The Effect of Intravenous Pyelography and Cystoscopy on the Staging of Cervical Cancer.  Gyn. Oncol. 3:87, 1975.
  26. van Nagell, J.R., Jr.; Pletsch, Q.A.; and Goldenberg, D.M.:  A Study of Cyst Fluid and Plasma Carcinoembryonic Antigen in Patient with Cystic Ovarian Neoplasms.  Cancer Res. 35:1433, 1975.
  27. Van Dyke, A.H. and van Nagell, J.R., Jr.:  The Prognostic Significance of Ureteral Obstruction in Patients with Recurrent Carcinoma of the Cervix Uteri.  Surg. Gynecol. Obstet. 141:371, 1975.
  28. van Nagell, J.R., Jr.; Parker, J.C., Jr.; Hicks, L.P.; Conrad, R.; and England, G.:  The Diagnostic and Therapeutic Efficacy of Cervical Conization.  Am. J. Obstet. Gynecol. 124:134, 1976.
  29. Maruyama, Y.; van Nagell, J.R., Jr.; Wrede, D.E.; Coffey, C.; Utley, J.F.; and Avila, J.:  Approaches to Optimization of Dose in Radiation Therapy of Cervix Carcinoma.  Am. J. Radiol. 120:389, 1976.
  30. van Nagell, J.R., Jr.; Meeker, W.R.; Parker, J.C., Jr.; Kashmiri, R.; and McCollum, V.:  Carcinoembryonic Antigen in Intraepithelial Neoplasia of the Uterine Cervix.  Am. J. Obstet. Gynecol. 126:105, 1976.
  31. van Nagell, J.R., Jr. and Schiwietz, D.P.:  Surgical Adjuncts in Radical Hysterectomy and Pelvic Lymphadenectomy.  Surg. Gynecol. and Obstet. 143:735, 1976.
  32. Goldenberg, D.M.; Pletsch, Q.A.; and van Nagell, J.R., Jr.:  Immunoperoxidase Localization of Carcinoembryonic Antigen in Squamous Cell Carcinoma of the Cervix.  Gyn. Oncol. 4:204, 1976.
  33. Glover, M.W. and van Nagell, J.R., Jr.:  The Effect of Prophylactic Ampicillin on Pelvic Infection Following Vaginal Hysterectomy.  Am. J. Obstet. Gynecol. 126:385, 1976.
  34. van Nagell, J.R., Jr.; Donaldson, E.S.; Maruyama, Y.; and Utley, J.:  The Management of Gynecologic Malignancy at the University of Kentucky Medical Center.  J. Ky. Med. Assoc. 74:829, 1976.
  35. Donaldson, E.S.; van Nagell, J.R., Jr.; Wood, E.G.; Pletsch, Q.A.; and Goldenberg, D.M.:  Carcinoembryonic Antigen in Patients Treated with Radiation Therapy for Invasive Squamous Cell Carcinoma of the Uterine Cervix.  Am. J. Roentgen. 127:829, 1976.
  36. van Nagell, J.R., Jr.; Parker, J.C., Jr.; Maruyama, Y.; Utley, J.; and Hager, W.D.:  The Effect of Pelvic Inflammatory Disease on Enteric Complications Following Radiation Therapy for Cervical Cancer.  Am. J. Obstet. Gynecol. 128:767, 1977.
  37. Parker, J.C., Jr.; Bissig, T.; and van Nagell, J.R., Jr.:  The Histomorphologic Spectrum of Endocervical (Mullerian) Adenocarcinoma - A Potential Prognostic Indicator.  J. Surg. Onc. 9:267-275, 1977.
  38. van Nagell, J.R., Jr.; Donaldson, E.S.; and Wood, E.G.:  Urinary Tract Involvement by Invasive Cervical Cancer.  Gynecologic and Obstetric Urology.  Buchsbaum, H. and Schmidt, J. (Eds.), W.B. Saunders, Philadelphia, 1977.
  39. van Nagell, J.R., Jr.; Donaldson, E.S.; Parker, J.C., Jr.; Van Dyke, A.H.; and Wood, E.G.:  The Prognostic Significance of Pelvic Lymph Node Morphology in Carcinoma of the Uterine Cervix.  Cancer 39:2624, 1977.
  40. van Nagell, J.R., Jr.; Donaldson, E.S.; Parker, J.C., Jr.; Van Dyke, A.H.; and Wood, E.G:  The Prognostic Significance of Cell Type and Lesion Size in Patients with Cervical Cancer Treated by Radical Surgery.  Gyn. Oncol. 5:142, 1977.
  41. van Nagell, J.R., Jr.; Donaldson, E.S.; Wood, E.G.; Maruyama, Y.; and Utley, J.:  Small Cell Cancer of the Uterine Cervix.  Cancer 40:2243, 1977.
  42. Maruyama, Y.; van Nagell, J.R., Jr.; Martin, A., et. al.:  Method for Localizing and Calculating Vaginal Dose in Brachytherapy.  Radiology 124:502, 1977.
  43. van Nagell, J.R., Jr.; Donaldson, E.S., Wood, E.G.; Sharkey, R.M.; and Goldenberg, D.M.:  The Prognostic Significance of Carcinoembryonic Antigen in the Plasma and Tumors of Patients with Endometrial Adenocarcinoma.  Am. J. Obstet. Gynecol. 128:308-313, 1977.
  44. van Nagell, J.R., Jr.; Donaldson, E.S.; Wood, E.G; and Parker, J.C.:  The Significance of Vascular Invasion and Lymphoplasmacytic Infiltration in Invasive Cancer of the Uterine Cervix.  Cancer 41:228, 1978.
  45. van Nagell, J.R., Jr.; Donaldson, E.S.; Wood, E.G.; and Goldenberg, D.M.:  The Clinical Significance of Carcinoembryonic Antigen in the Plasma and Tumors of Patients with Gynecologic Malignancies.  Cancer 42:1527, 1978.
  46. van Nagell, J.R., Jr.; Donaldson, E.S.; and Gay, E.C.:  The Evaluation and Treatment of Patients with Invasive Cervical Carcinoma.  Surg. Clin. N. Amer. 58:57-85, 1978.
  47. Maruyama, Y.; Feola, J.M.; Tai, D.; Wilson, L.C.; and van Nagell, J.R., Jr.:  Californium Cf-252 for Pelvic Radiotherapy.  Oncol. 35:172-178, 1978.
  48. Goldenberg, D.M.; Garner, T.F.; Pant, K.D.; and van Nagell, J.R., Jr.:  Isolation of  -Oncofetal Antigen (BOFA) from Cervical Squamous Cancer, and its Demonstration in Neoplastic and Normal Tissues.  Cancer Res. 38:246-249, 1978.
  49. van Nagell, J.R., Jr.; Donaldson, E.S.; Gay, E.C.; Rayburn, P.; Powell, D.F.; and Goldenberg, D.M.:  Carcinoembryonic Antigen in Carcinoma of the Uterine Cervix:  1.  The Prognostic Value of Serial Plasma Determinations.  Cancer 42:2428-2434, 1978.
  50. Goldenberg, D.M.; Deland, F.; Kim, E.; Bennett, S.; Primus, F.J.; van Nagell, J.R., Jr.; Estes, N.; DeSimone, P.; and Rayburn, P.:  Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External Photoscanning.  N. Eng. J. of Med. 298:1384-1388, 1978.
  51. van Nagell, J.R., Jr.; Donaldson, E.S.; Gay, E.C.; Sharkey, R.M.; Rayburn, P.; and Goldenberg, D.M.:  Carcinoembryonic Antigen in Ovarian Epithelial Cystadenocarcinomas:  Prognostic Value of Serial Plasma Determination.  Cancer 41:2335-2340, 1978.
  52. Donaldson, E.S. and van Nagell, J.R., Jr.:  Evaluation and Management of Vulvar Malignancies.  J. of Ky. Med. Assoc. 76:211-215, 1978.
  53. Maruyama, Y.; Yoneda, J.; and van Nagell, J.R., Jr.:  Potential for Low Dose Rate Neutron Brachytherapy for Pelvic Tumors.  Int. J. Rad. Oncol. Biol. Phys. 4:1, 47, 1978.
  54. Maull, K.I.; van Nagell, J.R., Jr.; Greenfield, L.J.:  Surgical Implications of Ovarian Vein Thrombosis.  Am. Surg. 44:727-733, 1978.
  55. Donaldson, E.S.; van Nagell, J.R., Jr.; Gay, E.C.; Purcell, S.; Meeker, W.R.; Kashmiri, R.; Hunter, L.; van der Voorte, J.:  Alpha-Fetoprotein as a Biochemical Marker in Patients with Gynecologic Malignancy.  Gyn. Oncol. 7:18, 1979.
  56. DeLand, M.; Fried, A.; van Nagell, J.R., Jr.; and Donaldson, E.S.:  Ultrasonography in the Diagnosis of Ovarian Tumors.  Surg. Gynecol. & Obstet. 148:346-348, 1979.
  57. Maruyama, Y. and van Nagell, J.R., Jr.:  Experience with an Alternative Method of Anesthesia for Intracavitary Therapy of Pelvic Carcinoma.  Radiology 132:216-217, 1979.
  58. van Nagell, J.R., Jr.; Kielar, R.; Donaldson, E.S.; Gay, E.C.; Powell, D.F.; Maruyama, Y.; and Yoneda, J.:  Correlation Between Retinal and Pelvic Vascular Status:  A Determinant Factor in Patients Undergoing Pelvic Irradiation for Gynecologic Malignancy.  Am. J. Obstet. Gynecol. 134:551-556, 1979.
  59. van Nagell, J.R., Jr.; Donaldson, E.S.; Gay, E.C.; Hudson, S.; Sharkey, R.M.; Primus, F.J.; Powell, D.F.; and Goldenberg, D.M.:  Carcinoembryonic Antigen in Carcinoma of the Uterine Cervix:  2.  Tissue Localization and Correlation with Plasma Antigen Concentration.  Cancer 44:944-948, 1979.
  60. Gallion, H.; van Nagell, J.R., Jr.; Powell, D.F.; Donaldson, E.S.; and Hanson, M.B.:  Therapy of Endodermal Sinus Tumor of the Ovary.  Am. J. Obstet. Gynecol. 135:447-451, 1979.
  61. van Nagell, J.R., Jr.; Donaldson, E.S.; Hanson, M.B.; and Gay, E.C.:  The Role of Carcinoembryonic Antigen in the Management of Patients with Gynecologic Cancer.  Am. J. Diagn. Obstet. & Gynecol. 1:103-107, 1979.
  62. van Nagell, J.R., Jr.; Rayburn, W.; Donaldson, E.S.; Hanson, M.B.; Gay, E.C.; Maruyama, Y.; Yoneda, J.; and Powell, D.:  Therapeutic Implications of Patterns of Recurrence in Cervical Cancer.  Cancer 44:2354-2361, 1979.
  63. van Nagell, J.R., Jr.:  Was hat der Augenhintergrund mit einer Krebsoperation zu tun.  Int. Woch. Aus. Deutsch. 14:2, 1979.
  64. Donaldson, E.S.; van Nagell, J.R., Jr.; Pursell, S.; Kashmiri, R.; Meeker, W.R.; van der Voorte, J.; and Gay, E.C.:  Multiple Biochemical Markers in Patients with Gynecologic Malignancies.  Cancer 45:948-953, 1980.
  65. Maruyama, Y.; Yoneda, J.; Krolikiewicz, H.; Mendiondo, O.; Beach, J.; Coffey, C.W.; Thompson, D.; van Nagell, J.R., Jr.; Donaldson, E.S.; and Powell, D.:  Report of Early Responses in a Clinical Therapy Trial for Advanced Cervico-Vaginal Pelvic Carcinomas Using Californium Cf-252 Fast Neutron Therapy.  Int. J. Rad. Oncol. Biol. Phys. 6:1629-1937, 1980.
  66. van Nagell, J.R., Jr.; Kim, E.; Casper, S.; Primus, F.J.; Bennett, S.; DeLand, F.H.; and Goldenberg, D.M.:  Radioimmunodetection of Primary and Metastatic Ovarian Cancer:  Use of Radiolabeled Antibodies to Carcinoembryonic Antigen.  Cancer Res. 40:502-506, 1980.
  67. Rayburn, W. and van Nagell, J.R., Jr.:  Vaginal Cytology in the Diagnosis of Recurrent Cervical Carcinoma.  Surg. Gynecol. & Obstet. 151:15-16, 1980.
  68. Goldenberg, D.M.; Kim, E.; DeLand, F.; van Nagell, J.R., Jr.; and Javadpour, N.:  Clinical Radioimmunodetection of Cancer Using Radioactive Antibodies to Human Chorionic Gonadotropin.  Science 208:1284-1286, 1980.
  69. van Nagell, J.R., Jr. and Goldenberg, D.M.:  Carcinoembryonic Antigen Staining of Endometrial and Endocervical Carcinomas.  The Lancet 1:213, 1980.
  70. Hanson, M.B.; Powell, D.E.; Donaldson, E.S.; and van Nagell, J.R., Jr.:  Treatment of Epithelial Ovarian Carcinoma by Surgical Debulking Followed by Single Alkylating Agent Chemotherapy.  Gyn. Oncol. 10:337-342, 1980.
  71. Sniecinski, I; Haley, J.; Morgan-Byrne, J.; and van Nagell, J.R., Jr.:  Association of HLA Antigens with Cervical and Endometrial Carcinomas.  Gyn. Oncol. 11:68-74, 1981.
  72. Donaldson, E.S.; Powell, D.F.; Hanson, M.B.; and van Nagell, J.R., Jr.:  Prognostic Parameters in Invasive Vulvar Cancer.  Gyn. Oncol. 11:184-190, 1981.
  73. van Nagell, J.R., Jr.; Donaldson, E.S.; Hanson, M.B.; Gay, E.C.; and Pavlik, E.J.:  Biochemical Markers in the Plasma and Tumors of Patients with Gynecologic Malignancies.  Cancer 48:495-503, 1981.
  74. Hardt, N.; van Nagell, J.R., Jr.; Hanson, M.; Donaldson, E.; Yoneda, J.; Maruyama, Y.:  Radiation Induced Tumor Regression as a Prognostic Factor in Patients with Invasive Cervical Cancer.  Cancer 49:35-39, 1982.
  75. van Nagell, J.R., Jr.; Hudson, S.; Gay, E.C.; Donaldson, E.S.; Hanson, M.B.; Powell, D.F.; and Goldenberg, D.M.:  Carcinoembryonic Antigen in Carcinoma of the Uterine Cervix.  3.  Antigen Distribution in Primary and Metastatic Tumors.  Cancer 49:379-383, 1982.
  76. Kamath, C.R.V.; Maruyama, Y.; DeLand, F.H.; and van Nagell, J.R., Jr.:  Value of Bone Scanning in Detecting Occult Skeletal Metastases from Adenocarcinoma of the Endometrium.  Am. J. Diagn. Gynecol. Obstet. 4:155-158, 1982.
  77. van Nagell, J.R., Jr.; Rapp, R.P.; May, J.R.; Donaldson, E.S.; Hanson, M.B.; and Forester, T.S.:  A Double-Blind Randomized Study of Cephapirin Versus Cephalothin Versus Ampicillin Used Prophylactically in Vaginal Hysterectomy.  Hosp. Form. 17:524-529, 1982.
  78. Pavlik, E.J.; van Nagell, J.R., Jr.; Muncey, M.; Donaldson, E.S.; Hanson, M.B.; Kenady, D.; Reese, E.D.; and Talwalkar, V.R.:  Rapid Analysis of Estrogen and Progesterone Receptors Using Gel Exclusion High Performance Liquid Chromatography.  Biochemistry 21:139, 1982.
  79. Maruyama, Y.; van Nagell, J.R., Jr.; Donaldson, E.S.; Hanson, M.B.; Powell, D.F.; and Muir, W.:  Tumor Regression and Histological Clearance After Neutron Brachytherapy for Large Localized Cervical Carcinomas by Combined Radiation and Surgery.  Cancer 50:2802-2809, 1982.
  80. Pavlik, E.J.; van Nagell, J.R., Jr.; Hanson, M.B.; Donaldson, E.S.; and Powell, D.E.:  Sensitivity to Anticancer Agents In Vitro:  Standardizing the Cytotoxic Response and Characterizing the Sensitivities of a Reference Cell Line.  Gyn. Oncol. 14:243-261, 1982.
  81. Maruyama, Y.; Bell, P.R.; Yoneda, J.; and van Nagell, J.R., Jr.:  Californium-252 Neutron Curietherapy for Advanced Cervical Cancer.  Onc. 39:209-215, 1982.
  82. Pavlik, E.J.; van Nagell, J.R., Jr.; Donaldson, E.S.; and Hanson, M.B.:  Some Practical Aspects of the Separation of Estrogen and Progesterone Receptors by Size Exclusion High Performance Liquid Chromatography which are Relevant to Quantitation.  J. Ster. Biochem. 7:553, 1982.
  83. Toedebusch, W.H.; Hagihara, P.F.; van Nagell, J.R., Jr.; and O'Connor, W.N.:  Adenocarcinoma of the Colon Associated with Benign Appendiceal Neoplasm.  Sou. Med. J. 75:893, 1982.
  84. Kamath, C.R.V.; Maruyama, Y; DeLand, F.H.; and van Nagell, J.R., Jr.:  Role of Bone Scanning for Evaluation of Carcinoma of the Cervix.  Gyn. Oncol. 15:171-185, 1983.
  85. Pavlik, E.J.; Kenady, D.E.; van Nagell, J.R., Jr.; Keaton, K.; Hanson, M.B.; Donaldson, E.S.; Griffen, W.O.; and Flanigan, R.C.:  Properties of Anticancer Agents Relevant to In Vitro Determinations of Human Tumor Cell Sensitivity.  Can. Chemo. Pharmacol. 11:8-15, 1983.
  86. Gallion, H.; van Nagell, J.R., Jr.; Donaldson, E.S.; Hanson, M.B.; and Powell, D.E.:  Immature Teratoma of the Ovary.  Am. J. Obstet. Gynecol. 146:361-365, 1983.
  87. van Nagell, J.R., Jr.; Greenwell, N.; Powell, D.F.; Donaldson, E.S.; Hanson, M.B.; and Gay, E.C.:  Microinvasive Carcinoma of the Cervix.  Am. J. Obstet. Gynecol. 145:981, 1983.
  88. Pavlik, E.J.; Flanigan, R.C.; van Nagell, J.R., Jr.; Swanson, L.; Keaton, K.; and Kenady, D.E.:  The Effect of Different Agars, Agaroses and Methyl Cellulose on the In Vitro Proliferation of a Human Urinary Transitional Cell Carcinoma Cell Line.  J. Urol. 129:1254-1257, 1983.
  89. van Nagell, J.R., Jr.:  Tumor Markers in Ovarian Cancer.  Clinics in Obstet. Gynec. 10:2, pp. 63-79, 1983.
  90. Pavlik, E.J.; Kenady, D.E.; van Nagell, J.R., Jr.; Keaton, K.; Donaldson, E.S.; Hanson, M.B.; and Flanigan, R.C.:  The Proliferation of Human Tumor Cell Lines in the Presence of Different Agars, Agaroses and Methyl Cellulose.  IN VITRO 19:538-550, 1983.
  91. Maruyama, Y.; van Nagell, J.R., Jr.; Yoneda, J.; Donaldson, E.S.; Hanson, M.B.; Martin, A.; Wilson, L.C.; Coffey, C.W.; Feola, J.; Beach, J.L.; and Logan, R.:  5-Year Survival in Cervical Cancer Treated Using Californium-252 Neutron Brachytherapy.  Am. J. Clin. Onc. 7:487-493, 1984.
  92. Casper, S.; van Nagell, J.R., Jr.; Powell, D.F.; Dubilier, L.D.; Donaldson, E.S.; Hanson, M.B.; and Pavlik, E.J.:  Immunohistochemical Localization of Tumor Markers in Epithelial Ovarian Cancer.  Am. J. Obstet. Gynecol. 149:154-158, 1984.
  93. Pavlik, E.J.; Kenady, D.E.; van Nagell, J.R., Jr.; Hanson, M.B.; Donaldson, E.S.; Casper, S.; Garrett, D.; Smith, D.; Keaton, K.; and Flanigan, R.C.:  The Stability of Doxorubicin in Relation to Chemosensitivity Determinations.  Loss of Lethality and Retention of Antiproliferative Activity.  Can. Invest. 2:449-458, 1984.
  94. Nelson, K.; Pavlik, E.J.; van Nagell, J.R., Jr.; Hanson, M.B.; Donaldson, E.S.; and Flanigan, R.C.:  Estrogenicity of Coumestrol in the Mouse:  Fluorescence Detection of Interactions with Estrogen Receptors.  Biochemistry 23:2565-2572, 1984.
  95. Pavlik, E.J.; Nelson, K.; van Nagell, J.R.; Jr.; Christian, J.; Hanson, M.B.; Bartmas, J.; Donaldson, E.S.; and Kenady, D.E.:  The Stability of VISICALC and VISIPLOT Software Routines for Handling Data Routinely Encountered by Steroid Biochemistry.  Steroids 43:393-398, 1984.
  96. Pant, K.D.; Ram, M.D., Hagihara, P.F.; Sachatello, C.R.; Griffen, W.O.; Rhoads, R.; Zamora, P.; Fulks, R.M.; and van Nagell, J.R., Jr.:  Characterization of the Common Antigen of Colorectal and Mucinous Ovarian Tumors (COTA).  Tumor Biol. 5:243-254, 1984.
  97. Maruyama, Y.; Beach, J.L.; and van Nagell, J.R., Jr.:  Californium-252:  Isotope for Modern Radiotherapy of Cervix, Uterine and Vaginal Carcinomas.  Strahlentherapie 160:373-381, 1984.
  98. Pavlik, E.J.; Flanigan, R.C.; van Nagell, J.R., Jr.; Hanson, M.B.; Donaldson, E.S.; Keaton, K.; Doss, B.; Bartmas, J.; and Kenady, D.E.:  Esterase Activity, Exclusion of Propidium Iodide and Proliferation in Tumor Cells Exposed to Anticancer Agents:  Phenomena Relevant to Chemo-Sensitivity Determinations.  Can. Invest. 3:413-425, 1985.
  99. Gallion, H.; van Nagell, J.R., Jr.; Donaldson, E.S.; Hanson, M.B.; Powell, D.E.; Maruyama, Y.; and Yoneda, J.:  Combined Radiation Therapy and Extrafascial Hysterectomy in the Treatment of Stage IB Barrel-Shaped Cervical Cancer.  Cancer 56:252-265, 1985.
  100. Hanson, M.B.; van Nagell, J.R., Jr.; Powell, D.E.; Donaldson, E.S.; Gallion, H.H.; Merhige, M.; and Pavlik, E.J.:  The Prognostic Significance of Lymph-Vascular Space Invasion in Stage I Endometrial Cancer.  Cancer 55:1753-1757, 1985.
  101. Maruyama, Y.; Feola, J.M.; and van Nagell, J.R., Jr.:  Heterotransplantation of Human Cervix Cancers in Radiation-Conditioned or Nonconditioned Athymic Mice.  Cancer 56:2635-2639, 1985.
  102. Maruyama, Y.; Kryscio, R.; van Nagell, J.R., Jr.; Yoneda, J.; Donaldson, E.; Hanson, M.; Beach, J.L.; Feola, J.M.; Martin, A.; and Parker, C.:  Clinical Trial of 252-Cf Neutron Brachytherapy versus Conventional Radiotherapy for Advanced Cervical Cancer.  Int. J. Rad. Oncol. Biol. Phys. 11:1475-1482, 1985.
  103. van Nagell, J.R., Jr.; Hanson, M.B.; Donaldson, E.S.; and Gallion, H.H.:  Treatment of Cervical Intraepithelial Neoplasia III by Hysterectomy Without Intervening Conization in Patients with Adequate Colposcopy.  Cancer 56:2737-2739, 1985.
  104. Flanigan, R.C.; Pavlik, E.J.; van Nagell, J.R., Jr.; Keaton, K.; Ragland, A.; and Kenady, D.E.:  Growth of Urinary Transitional Cell Carcinoma Cell Lines in Agar, Agarose and Methyl Cellulose.  J. Urology 134:985-990, 1985.
  105. Pavlik, E.J.; Nelson, K.; van Nagell, J.R., Jr.; Robinson, J.C.; Hanson, M.B.; Donaldson, E.S.; Flanigan, R.C.; and Kenady, D.E.:  Steroid Receptor Analysis by Size-Exclusion Liquid Chromatography:  Considerations for the Clinical Laboratory.  Clin. Chem. 31:537-545, 1985.
  106. Baranowska-Kortylewicz, J.; Pavlik, E.J.; Smith, W.T., Jr.; Flanigan, R.C.; van Nagell, J.R., Jr.; Ross, D.; and Kenady, D.E.:  Dichloro(6-aminoethyl-aminourine)platinum(II) and its Hydroxy Analogues:  Synthesis and Preliminary Evaluation.  Inorganica Chimica Acta. 108:91-98, 1985.
  107. Pavlik, E.J.; Nelson, K.; van Nagell, J.R., Jr.; Donaldson, E.S.; Walden, M.L.; Hanson, M.B.; Gallion, H.; Flanigan, R.C.; and Kenady, D.E.:  Hydrodynamic Characterizations of Estrogen Receptors Complexed with [3H]-4-Hydroxytamoxifen:  Evidence in Support of Contrasting Receptor Transitions Mediated by Different Ligands.  Biochemistry 24:8101-8106, 1985.
  108. Maruyama, Y.; van Nagell, J.R., Jr.; Donaldson, E.; Beach, J.L.; Martin, A.; Kryscio, R.; Yoneda, J.; Hanson, M.; Feola, J.M.; and Parker, C.:  Neutron Brachytherapy is Better than Conventional Radiotherapy in Advanced Cervical Cancer.  The Lancet 1:1120-1122, 1985.
  109. van Nagell J.R., Jr.; Maruyama, Y.; Yoneda, J.; Donaldson, E.S.; Hanson, M.B.; Gallion, H.H.; Powell, D.E.; and Kryscio, R.J.:  Treatment of Bulky Stage IB and IIB Cervical Cancers with Outpatient Neutron Brachytherapy, External Pelvic Radiation and Extrafascial Hysterectomy.  Nuc. Sci. Appl.  2:483-484, 1986.
  110. Pavlik, E.J.; Flanigan, R.C.; Bartmas, J.; van Nagell, J.R., Jr.; Donaldson, E.S.; and Kenady, D.E.:  Programming for the DNA Analysis of FCM Data on an IBM Microcomputer.  Cytometry 7:93-97, 1986.
  111. Pavlik, E.J.; van Nagell, J.R., Jr.; Nelson, K.; Gallion, H.; Donaldson, E.S.; Kenady, D.E.; and Baranowska-Kortylewicz, J.:  Antagonism to Estradiol in the Mouse:  Reduced Entry of Receptors Complexed with 40H-Tamoxifen into a Mg++-soluble Chromatin Fraction.  Endocrinology 118:1924-1934, 1986.
  112. van Nagell, J.R., Jr.; Maruyama, Y.; Donaldson, E.S.; Hanson, M.B.; Gallion, H.H.; Yoneda, J.; Powell, D.E.; and Kryscio, R.J.:  Phase II Clinical Trial Using Californium-252 Fast Neutron Brachytherapy, External Pelvic Radiation and Extrafascial Hysterectomy in the Treatment of Bulky, Barrel-Shaped Stage IB Cervical Cancers.  Cancer 57:1918-1922, 1986.
  113. van Nagell, J.R., Jr.; Hanson, M.B.; Donaldson, E.S.; and Gallion, H.H.:  Adjuvant Vincristine, Actinomycin-D and Cyclophosphamide (VAC) Therapy in Stage I Uterine Sarcomas:  A Pilot Study.  Cancer 57:1451-1454, 1986.
  114. Flanigan, R.C.; Pavlik, E.J.; van Nagell, J.R., Jr.; Keaton, K; and Kenady, D.E.:  Proliferation, Esterase Activity and Propidium-Iodide Exclusion in Urologic Tumor Cells After In Vitro Exposure to Chemotherapeutic Agents.  J. Urol. 135:1091-1100, 1986.
  115. Gallion, H.H.; van Nagell, J.R., Jr.; Donaldson, E.S.; and Powell, D.E.:  Endometrial Cancer Following Radiation Therapy for Cervical Cancer.  Gyn. Oncol. 27:77-83, 1986.
  116. Pavlik, E.J.; Nelson, K.; Gallion, H.; van Nagell, J.R., Jr.; Pursell, S.; Donaldson, E.S.; Flanigan, R.C.; and Kenady, D.E.:  The Effects of Acute Administration of Cytotoxic Anticancer Agents on the Capacity for Subsequent Hormonal Responses in the Mouse Uterus.  J. Steroid Biochem. 25:231-237, 1986.
  117. Rapp, R.P.; Connors, J.E.; Hager, W.D.; Donaldson, E.S.; and van Nagell, J.R., Jr.:  Comparison of Single Dose Moxalactam And a Three Dose Regimen of Cefoxitin for Prophylaxis in Vaginal Hysterectomy.  Clin. Pharm. 5:988-993, 1986.
  118. Maruyama, Y.; van Nagell, J.R., Jr.; Kryscio, R.; Yoneda, J.; Beach, J.L.; Feola, J.M.; Donaldson, E.S.; Hanson, M.; and Gallion, H.:  Lexington Studies of Cf-252 Brachytherapy for Advanced Cervical and Uterine Cancer.  Nuc. Sci. Applications 2:467-482, 1986.
  119. Wermeling, D.A.; Foster, T.S.; Farrington, E.A.; Witt, W.O.; Gallion, H.H.; Donaldson, E.S.; van Nagell, J.R., Jr.; Outman, W.R.; McPerson, D.P.:  Patient-Controlled Analgesia Using Butorphanol for Postoperative Pain Relief:  An Open Label Study.  Acute Care 12:25-33, 1986.
  120. Gallion, H.H.; van Nagell, J.R., Jr.; Donaldson, E.S.; Hanson, M.B.; and Kryscio, R.J.:  Prognostic Implications of Large Volume Residual Disease in Patients with Advanced Stage Epithelial Ovarian Cancer.  Gyn. Oncol. 27:220-225, 1987.
  121. Gallion, H.H.; Maruyama, Y.; van Nagell, J.R., Jr.; Donaldson, E.S.; Rowley, K.C.; Yoneda, J.; Beach, J.L.; Powell, D.E.; and Kryscio, R.J.:  Treatment of Stage IIIB Cervical Cancer with Californium-252 Fast Neutron Brachytherapy and External Photon Therapy.  Cancer 59:1709-1712, 1987.
  122. van Nagell, J.R., Jr.; Dudik, L.M.; Frank, A.L.; Allen, D.T.; Leigh, J.P.; and Engelberg, J.:  Cervical Cancer.  Sou. Med. J. 80:75-81, 1987.
  123. Pavlik, E.J.; Nelson, K.; van Nagell, J.R., Jr.; Donaldson, E.S.; Walden, M.L.; Gallion, H.; and Kenady, D.E.:  Extensive in Situ Activation of Nuclear Estrogen Receptors after Exposure of Murine Uteri to [3H] Estradiol or [3H]4-Hydroxytamoxifen*.  Endocrinology 120:1608-1614, 1987.
  124. Maruyama, Y.; van Nagell, J.R., Jr.; Yoneda, J.; Donaldson, E.; Gallion, H.; Rowley, K.; Kryscio, R.; and Beach, J.L.:  Phase I-II Clinical Trial of Californium-252.  Treatment of Stage IB Carcinoma of the Cervix.  Cancer 59:1500-1505, 1987.
  125. Baranowska-Kortylewicz, J.; Nelson, K.; Pavlik, E.J.; van Nagell, J.R., Jr.; Gallion, H.H.; Donaldson, E.S.; and Kenady, D.E.:  Identification of a Very Large Nuclear Estrogen Receptor Complex.  Endocrinology 120:2189-2191, 1987.
  126. Pavlik, E.J.; Nelson, K.; van Nagell, J.R., Jr.; Gallion, H.H.; and Baranczuk, R.J.:  High Performance Liquid Chromatography of Steroid Receptor Proteins:  Rapid High Resolution Characterizations and the Opportunity for Resource Conservation.  In Molecular Mechanisms of Steroid Hormone Action, edited by Arun Roy and V.K. Moudgil, Walter De Gruyter, New York.  477-498, 1987.
  127. Gallion, H.H.; Wermeling, D.; Foster, T.; van Nagell, J.R., Jr.; and Donaldson, E.S.:  Patient-Controlled Analgesia in Gynecologic Oncology.  Gyn. Oncol. 27:247-252, 1987.
  128. Maruyama, Y.; van Nagell, J.R., Jr.; Feola, J.M.; Beach, J.L.; Yoneda, J.; Donaldson, E.; Gallion, H.; Rowley, K.; and Powell, D.:  Specimen Histology After One or Two Preoperative Cf-252 Implants for Bulky Stage IB Cervical Cancer.  Int. J. Rad. Oncol. Biol. Phys. 13:1473-1478, 1987.
  129. Maruyama, Y.; van Nagell, J.R., Jr.; Yoneda, J.; Donaldson, E.; Gallion, H.; Powell, D.; Higgins, R.V.; Turner, C.; Kryscio, R.:  Efficacy of Brachytherapy with Californium-252 Neutrons vs. Cesium-137 Photons for Eradication of Bulky Localized Cervix Cancer.  J. Nat. Cancer Inst. 80:501-506, 1988.
  130. Gallion, H.H.; van Nagell, J.R., Jr.; Donaldson, E.S.; Powell, D.E.:  Ovarian Dysgerminoma:  Report of Seven Cases and Review of the Literature.  Am. J. Obstet. Gynecol. 158:591-595, 1988.
  131. van Nagell, J.R., Jr.; Powell, D.E.; Gallion, H.H.; Elliott, D.G.; Donaldson, E.S.; Carpenter, A.E.; Higgins, R.V.; Kryscio, R.; Pavlik, E.J.:  Small Cell Carcinoma of the Uterine Cervix.  Cancer 62:1586-1593, 1988.
  132. Maruyama, Y.; van Nagell, J.R., Jr.; Yoneda, J.; Donaldson, E.; Gallion, H.H.; Powell, D.; Beach, J.L.; Turner, C.; Kryscio, R.:  Dose-Response for Cf-252 Neutron Brachytherapy by Histological Eradication of Bulky Stage IB Cervical Tumors.  Endocurietherapy/Hyperthermia Oncology 5:111-120, 1989.
  133. Rowley, K.C.; Gallion, H.H.; Donaldson, E.S.; van Nagell, J.R., Jr.; Higgins, R.V.; Powell, D.E.; Kryscio, R.J.; Pavlik, E.J.:  Prognostic Factors in Early Vulvar Cancer.  Gynecol. Oncol. 31:43-49, 1988.
  134. Gallion, H.H.; van Nagell, J.R., Jr.; Donaldson, E.S.; Higgins, R.V.; Powell, D.E.; Kryscio, R.J.:  Adjuvant Oral Alkylating Chemotherapy in Patients with Stage I Epithelial Ovarian Cancer.  Cancer 63:1070-1073, 1989.
  135. Gallion, H.H.; van Nagell, J.R., Jr.; Donaldson, E.S.; Higgins, R.V.; Tietz, N.W.:  Successful Salvage Therapy of Gestational Trophoblastic Disease with Etoposide, Methotrexate, Actinomycin D, Vincristine, and Cyclophosphamide.  Gynecol. Oncol. 34:98-100, 1989.
  136. Maruyama, Y.; van Nagell, J.R., Jr.; Yoneda, J.; Donaldson, E.; Gallion, H.; Higgins, R.V.; Powell, D.; Turner, C.; Kryscio, R.:  Dose-Response and Failure Pattern by Combined Photon Radiation and Extrafascial Hysterectomy for Bulky, Barrel Stage IB Cervical Cancers.  Cancer 63:70-76, 1989.
  137. Donaldson, E.S; Higgins, R.V.; Gallion, H.H.; van Nagell, J.R., Jr.:  The Role of Implantable Central Venous Access Devices (CVAD) in the Administration of Intravenous Chemotherapy to Patients with Gynecologic Malignancies.  Gynecol. Oncol. 32:98, 1989.
  138. Gallion, H.H.; van Nagell, J.R., Jr.; Donaldson, E.S.; Higgins, R.V.; Powell, D.E.; Kryscio, R.:  The Prognostic Significance of Abnormal Cervical Cytology after Radiation Therapy for Cervical Cancer.  Gynecol. Oncol. 32:98, 1989.
  139. Gallion, H.H.; van Nagell, J.R., Jr.; Powell, D.E.; Donaldson, E.S.; Higgins, R.V.; Kryscio, R.J.; Pavlik, E.J.; Nelson, K.:  Stage I Serous Papillary Carcinoma of the Endometrium.  Cancer 63:2224-2228, 1989.
  140. Higgins, R.V.; van Nagell, J.R., Jr.; Donaldson, E.S.; Gallion, H.H.; Pavlik, E.J.; Endicott, B.; Woods, C.H.:  Transvaginal Sonography as a Screening Method for Ovarian Cancer.  Gynecol. Oncol. 34:402-406, 1989.
  141. Nelson, Katherine; Baranowska-Kortylewicz, J; van Nagell, J.R., Jr.; Gallion, H.H.; Donaldson, E.S.; Kenady, D.E.; McRoberts, W.P.; Pavlik, E.J.:  Intermolecular Engagement of Estrogen Receptors Indicated by the Formation of a High Molecular Weight Complex during Activation.  Biochemistry 28:9741, 1989.
  142. Saphner, T.; Gallion, H.H.; van Nagell, J.R., Jr.; Patchell, R.A.:  Neurologic Complications of Cervical Cancer - Review of 2244 Cases.  Cancer 64:1147-1151, 1989.
  143. Higgins, R.V.; Gallion, H.H.; Donaldson, E.S.; van Nagell, J.R., Jr.; Powell, D.E.; Kryscio, R.J.:  The Efficacy of Laser Therapy in the Treatment of Cervical Intraepithelial Neoplasia (CIN).  Gynecol. Oncol. 36:79-81, 1990.
  144. Maruyama, Y.; van Nagell, J.R., Jr.; Yoneda, J.; Donaldson, E.S.; Gallion, H.H.; Higgins, R.; Kryscio, R.J.:  Cure of Cervical Cancer Using 252-Cf Neutron Brachytherapy.  Strahlenther. Onkol. 166:317-321, 1990.
  145. van Nagell, J.R., Jr.; Higgins, R.V.; Donaldson, E.S.; Gallion, H.H.; Powell, D.E.; Pavlik, E.J.; Woods, C.H.; and Thompson, E.A.:  Transvaginal Sonography as a Screening Method for Ovarian Cancer:  A Report of the First 1000 Cases Screened.  Cancer 65:573-577, 1990.
  146. Higgins, R.V.; van Nagell, J.R., Jr.; Woods, C.H.; Thompson, E.A.; Kryscio, R.K.:  Interobserver Variation in Ovarian Measurements Using Transvaginal Sonography.  Gynecol. Oncol. 39:69-71, 1990.
  147. Pavlik, E.J.; Nelson, K.; Gallion, H.H., van Nagell, J.R., Jr.; Donaldson, E.S.; Shih, W.J.; Spicer, J.A.; Preston, D.F.; Baranczuk, R.J.; and Kenady, D.E.:  Characterization of High Specific Activity [16alpha-123]Iodo-estradiol 17,beta as an Estrogen Receptor Specific Radioligand Capable of Imaging Estrogen Receptor-Positive Tumors.  Can. Res. 50:7799-7805, 1990.
  148. Gallion, H.H.; Powell, D.E.; Smith, L.W.; Morrow, J.K.; van Nagell, J.R., Jr.; Donaldson, E.S.; Higgins, R.V.:  Chromosome Abnormalities in Human Epithelial Ovarian Malignancies.  Gynecol. Oncol. 38:473-477, 1990.
  149. Maruyama, Y.; Feola, J.M.; Wierzbicki, J.; van Nagell, J.R., Jr.; Powell, D.; Yoneda, J.; Donaldson, E.; Gallion, H.; Higgins, R.:  Clinical Study of Relative Biological Effectiveness for Cervical Carcinoma Treated by Cf-252 Neutrons and Assessed by Histological Tumour Eradication.  Br. J. Radiology 63:270-277, 1990.
  150. Maruyama, Y.; van Nagell, J.R.; Yoneda, J.; Donaldson, E.S.; Gallion, H.H.; Higgins, R.; Kryscio, R.J.:  Cf-252 Neutron Brachytherapy Treatment for Cure of Cervical Cancer.  Nuc. Sci. Applic. 4:181-192, 1991.
  151. van Nagell, J.R., Jr.:  Ovarian Cancer Screening.  Editorial.  Cancer 68:679-680, 1991.
  152. van Nagell, J.R., Jr.; DePriest, P.D.; Puls, L.E.; Donaldson, E.S.; Gallion, H.H.; Pavlik, E.J.; Powell, D.E.; Kryscio, R.J.:  Ovarian Cancer Screening in Asymptomatic Postmenopausal Women by Transvaginal Sonography.  Cancer 68:458-462, 1991.
  153. DePriest, P.; Gallion, H.; van Nagell, J.R., Jr.:  Uterine Sarcoma.  Postgrad. Gen. Surg. 3:22-25, 1991.
  154. Maruyama, Y.; van Nagell, J.R., Jr.; Yoneda, J.; Donaldson, E.S.; Gallion, H.H.; Powell, D.; and Kryscio, R.J.:  A Review of Californium-252 Neutron Brachytherapy for Cervical Cancer.  Cancer 68:1189-1197, 1991.
  155. Higgins, R.V.; van Nagell, J.R., Jr.; Horn, E.J.; Roberts, S.L.; Donaldson, E.S.; Gallion, H.H.; DePriest, P.D.; Powell, D.E.; and Kryscio, R.J.:  Preoperative Radiation Therapy Followed by Extrafascial Hysterectomy in Patients with Stage II Endometrial Carcinoma.  Cancer 68:1261-1264, 1991.
  156. Maruyama, Y.; van Nagell, J.R.; Yoneda, J.; Donaldson, E.S.; Gallion, H.H.:  Efficacy for Cf-252 Neutrons for Control of Hemorrhage/Infection in Advanced Bulky Gynecological Cancer.  Nuc. Sci. Applic. 4:429-434, 1991.
  157. Maruyama, Y.; Donaldson, E.S.; van Nagell, J.R., Jr.; Yoneda, J.; Gallion, H.H.; Powell, D.; and Kryscio, R.J.:  Specimen Findings and Survival After Pre-Operative 252Cf Neutron Brachytherapy for Stage II Cervical Carcinoma.  Gynecol. Oncol. 43:252-259, 1991.
  158. van Nagell, J.R., Jr.:  Editorial - Ovarian Cancer Screening.  Gynecol. Oncol. 43:89-91, 1991.
  159. Pavlik, E.J.; Nelson, K.; van Nagell, J.R., Jr.; Gallion, H.H.; Donaldson, E.S.; DePriest, P.D.; Meares, K.; van Nagell, J.R., III:  The Growth Response of BG-1 Ovarian Carcinoma Cells to Estradiol, 40H-Tamoxifen and Tamoxifen:  Evidence for Intrinsic Antiestrogen Activation.  Gynecol. Oncol. 42:245-249, 1991.
  160. Maruyama, Y.; van Nagell, J.R., Jr.; Powell, D.; Yoneda, J.; Donaldson, E.; Gallion, H.; Kryscio, R.J.:  Predictive Value of Specimen Histology after Preoperative Radiotherapy in the Treatment of Bulky-Barrel Carcinoma of the Cervix.  Am. J. Clin. Oncol. 15:150-156, 1992.
  161. Pavlik, E.J.; Nelson, K.; Srinivasan, S.; Powell, D.E.; Kenady, D.E.; DePriest, P.D.; Gallion, H.H.; van Nagell, J.R., Jr.:  Resistance to Tamoxifen and Persisting Sensitivity to Estrogen Mediated by Excessive Antiestrogen Binding Site Activity.  Cancer Res. 52:1-7, 1992.
  162. Powell, D.E.; Puls, L.J.; van Nagell, J.R., Jr.:  Current Concepts in Epithelial Ovarian Tumors:  Does Benign to Malignant Transformation Occur?  Current Topics 23:846-847, 1992.
  163. Gallion, H.; Hunter, J.E.; Averette, H.; Partridge, E.; Copeland, L.; Cain, J.; Husseinzadeh, N.; Nahhas, W.; Pursell, S.; Higgins, R.; van Nagell, J.R., Jr.; DePriest, P.D.; Maggard, A.; Kryscio, R.:  The Prognostic Implications of Low Serum CA-125 Levels Prior to Second-Look Operation for Stage III and IV Epithelial Ovarian Cancer.  Gynecol. Oncol. 46:29-32, 1992.
  164. DePriest, P.D. and van Nagell, J.R., Jr.:  Transvaginal Ultrasound Screening for Ovarian Cancer.  Clin. Obstet. & Gynecol. 35:40-44, 1992.
  165. DePriest, P.D.; Banks, E.R.; van Nagell, J.R., Jr.; Gallion, H.; Puls, L.E.; Hunter, J.E.:  Endometrioid Carcinoma of the Ovary and Endometriosis:  Association in Postmenopausal Patients.  Gynecol. Oncol. 47:71-75, 1992.
  166. Puls, L.E.; Powell, D.E.; van Nagell, J.R., Jr.; Gallion, H.; DePriest, P.D.; Hunter, J.E.:  Transition from Benign to Malignant Epithelium in Mucinous and Serous Ovarian Tumors.  Gynecol. Oncol. 47:53-57, 1992.
  167. Gallion, H.H.; Powell, D.E., Hunter, J.E.; Morrow, J.K.; Pieretti, M.; Case, E.; Turker, M.S.; DePriest, P.D.; van Nagell, J.R., Jr.:  Molecular Genetic Changes in Human Epithelial Ovarian Malignancies.  Gynecol. Oncol. 45:82-83, 1992.
  168. van Nagell, J.R., Jr.; DePriest, P.D.; Gallion, H.H.; Pavlik, E.J.:  Ovarian Cancer Screening.  Cancer 71:1523-1528, 1993.
  169. van Nagell, J.R., Jr. and DePriest, P.D.:  Ovarian Cancer Screening.  Principles and Practice of Gynecologic Oncology Updates.  1:1-5, 1993.
  170. Maruyama, Y.; van Nagell, J.R., Jr.; Yoneda, J.; Gallion, H.H.; DePriest, P.; Feola, J.M.; and Wierzbicki, J.:  Schedule in Cf-252 Neutron Brachytherapy:  Complications after Delayed Implant Therapy for Cervical Cancer in a Phase II Trial.  Am. J. Clin. Oncol. 16:168-174, 1993.
  171. Puls, L.E.; Davey, D.D.; DePriest, P.D.; Gallion, H.H.; van Nagell, J.R., Jr.; Hunter, J.E.; and Pavlik, E.J.:  Immunohistochemical Staining for Ca-125 in Fallopian Tube Carcinomas.  Gynecol. Oncol. 48:360-363, 1993.
  172. Higgins, R.V.; Schwartz, R.W.; DePriest, P.D.; van Nagell, J.R., Jr.:  Metastatic Gastric Carcinoma Presenting as a Pelvic Mass.  J. Ky. Med. Assoc. 91:193-194, 1993.
  173. Maruyama, Y.; van Nagell, J.R., Jr.; Yoneda, J.; Gallion, H.H.; DePriest, P.D.; and Kryscio, R.J.:  Clinical Evaluation of 252CF Intracavitary Therapy for Primary Endometrial Adenocarcinoma.  Cancer 71:3932-3937, 1993.
  174. Pavlik, E.J.; Nelson, K.; Srinivasin, S.; Meares, K.; van Nagell, J.R., Jr.; DePriest, P.D.; Gallion, H.S.; van Nagell, J.R., III; and Kenady, D.E.:  The Pure Antiestrogen ICI-164384 Interacts with Estrogen Receptors and Non-estrogen Receptor Molecules in Rodent and Human Preparations.  Endocrine Journal 1:147-155, 1993.
  175. DePriest, P.D.; Shenson, D.; Fried, A.; Hunter, J.E.; Andrews, S.J.; Gallion, H.H.; Pavlik, E.J.; Kryscio, R.J.; van Nagell, J.R., Jr.:  A Morphology Index Based on Sonographic Findings in Ovarian Cancer.  Gynecol. Oncol. 51:7-11, 1993.
  176. Kenady, D.E.; Pavlik, E.J.; Nelson, K.; van Nagell, J.R., Jr.; Gallion, H.H.; DePriest, P.D.; Ryo, U.Y.; Baranczuk, R.J.:  Images of ERc-Positive Breast Tumors Produced by 16a-[123I] Estradiol.  Arch. Surg. 128:1373-1381, 1993.
  177. DePriest, P.D.; van Nagell, J.R., Jr.; Gallion, H.H.; Shenson, D.; Hunter, J.E.; Andrews, S.J.; Powell, D.E.; Pavlik, E.J.:  Ovarian Cancer Screening in Asymptomatic Postmenopausal Women.  Gynecol. Oncol. 51:205-209, 1993.
  178. Maruyama, Y.; Yoneda, J.; van Nagell, J.R., Jr.; Gallion, H.H.; DePriest, P.D.; and Kryscio, R.J.:  An Evaluation of Postoperative Radiotherapy vs Observation for Operable Cervical Cancer Treated with Preoperative Radiation.  Endocur. Hyper. Onc. 9:173-180, 1993.
  179. Maruyama, Y.; Bowen, M.G.; van Nagell, J.R., Jr.; Gallion, H.H.; DePriest, P.D.; and Wierzbicki, J.:  A Feasibility Study of 252Cf Neutron Brachytherapy, Cisplatin + 5-FU Chemo-Adjuvant and Accelerated Hyperfractionated Radiotherapy for Advanced Cervical Cancer.  Int. J. Radiat. Oncol. Biol. Phys. 29:529-534, 1994.
  180. van Nagell, J.R., Jr.:  Methods to Improve the Diagnostic Accuracy of Ultrasound in the Detection of Ovarian Cancer.  Editorial.  Gynecol. Oncol. 54:115-116, 1994.
  181. Andrews, S.J.; Williams, B.; DePriest, P.D.; Gallion, H.H.; Hunter, J.E.; Buckley, S.L.; Kryscio, R.J.; and van Nagell, J.R., Jr.:  Therapeutic Implications of Lymph Nodal Spread in Lateral T1 and T2 Squamous Cell Carcinoma of the Vulva.  Gynecol. Oncol. 55:41-46, 1994.
  182. Hunter, J.E.; Tritz, D.E.; Howell, M.G.; DePriest, P.D.; Gallion, H.H.; Andrews, S.J.; Buckley, S.L.; Kryscio, R.J.; and van Nagell, J.R., Jr.:  The Prognostic and Therapeutic Implications of Cytologic Atypia in Patients with Endometrial Hyperplasia.  Gynecol. Oncol. 55:66-71, 1994.
  183. van Nagell, J.R., Jr.  Presidential Address.  The Society of Gynecologic Oncologists - A Tradition of Excellence.  Gynecol. Oncol. 55:1-5, 1994.
  184. DePriest, P.D.; Varner, E.; Powell, J.; Fried, A.; Puls, L.; Higgins, R.; Shenson, D.; Kryscio, R.; Hunter, J.; Andrews, S.J.; van Nagell, J.R., Jr.:  The Efficacy of a Sonographic Morphology Index in Identifying Ovarian Cancer:  A Multi-Institutional Investigation.  Gynecol. Oncol. 55:174-178, 1994.
  185. Maruyama, Y.; van Nagell, J.R., Jr.; Yoneda, J.; Powell, D.; Gallion, H.H.; DePriest, P.D.; and Kryscio, R.J.:  Histologic Monitoring of Tumor Response After Preoperative Radiotherapy for Stage IB/II Cervical Cancer.  Endocur. Hyper. Onc. 10:97-104, 1994.
  186. Pavlik, E.J.; van Nagell, J.R., Jr.; DePriest, P.D.; Wheeler, L.; Tatman, J.M.; Boone, M.; Sollars, S.; Rayens, M.K.; and Kryscio, R.J.:  Participation in Transvaginal Ovarian Cancer Screening:  Compliance, Correlation Factors, and Costs.  Gynecol. Oncol. 57:395-400, 1995.
  187. van Nagell, J.R., Jr.; Gallion, H.H.; Pavlik, E.J.; DePriest, P.D.:  Ovarian Cancer Screening.  Cancer 76:2086-2091, 1995.
  188. Gallion, H.H.; Pieretti, M.; DePriest, P.D.; van Nagell, J.R., Jr.:  The Molecular Basis of Ovarian Cancer.  Cancer 76:1992-1997, 1995.
  189. Puls, L.E.; DePriest, P.D.; Morrow, S.; Hunter, J.E.; Blackhurst, D.; Jurnalov, C.J.; van Nagell, J.R., Jr.:  Cost Analysis of Managing Ovarian Carcinoma Patients.  Gynecol. Oncol. 60:134, 1996.
  190. DePriest, P.D. and van Nagell, J.R., Jr.:  Ovarian Cancer Screening.  Curr. Prob. in Obstet. Gynecol. & Fert. 19:103-109, 1996.
  191. Francke, P.; Maruyama, Y.; van Nagell, J.R., Jr.; DePriest, P.:  Lymphvascular Invasion in Stage IB Cervical Carcinoma:  Prognostic Significance and Role of Adjuvant Radiotherapy.  Int. J. Gynecol. Cancer 6:208-212, 1996.
  192. Gallion, H.H.; Guarino, d.A.; DePriest, P.D.; van Nagell, J.R., Jr.; Vacarello, L.; Berek, D.; Pieretti, M.:  Evidence for a Unifocal Origin in Familial Ovarian Cancers.  Am. J. Obstet. Gynecol. 174:1102-1106, 1996.
  193. Buckley, S.L.; Tritz, D.M.; Van Le, L.; Higgins, R.; Sevin, B.U.; Ueland, F.R.; DePriest, P.D.; Gallion, H.H.; Bailey, C.L.; Kryscio, R.J.; Fowler, W.; Averette, H.; and van Nagell, J.R., Jr.:  Lymph Node Metastases and Prognosis in Patients with Stage IA2 Cervical Cancer.  Gynecol. Oncol.  63:4-9,1996.
  194. DePriest, P.D.; Buckley, S.L.; Bailey, C.L.; Gallion, H.H.; Pavlik, E.J.; Kryscio, R.J.; van Nagell, J.R., Jr.:  Transvaginal Sonography as a Screening Method for the Detection of Early Ovarian Cancer.  Gynecol. Oncol. 65:408-414,1997.
  195. Bailey, C.L.; Ueland, F.R.; Land, G.L.; DePriest, P.D.; Gallion, H.H.; Kryscio, R.J.; and van Nagell, J.R., Jr.:  Malignant Potential of Small Cystic Ovarian Tumors in Postmenopausal Women.  Gynecol. Oncol. 69:3-7,1998.
  196. Reedy, M.B.; Richards, W.E.; Ueland, F., Uy, K.; Lee, E.Y.; Bryant, C.; van Nagell, J.R., Jr.:  Ovarian Steroid Cell Tumors, Not Otherwise Specified:  A Case Report and Literature.  Gynecol. Oncol.  75:293-297, 1999.
  197. Cardosi, R.J.; Reedy, M.B.; Spires, S.; van Nagell, J.R., Jr.:  Neuroendocrine Signet Ring Cell Adenocarcinoma of the Endocervix.  Int. J. Gynecol Cancer 9:433-437, 1999.
  198. van Nagell, J.R., Jr.; Ueland, F.R.:  Ultrasound Evaluation of Pelvic Masses:  Predictors of Malignancy for the General Gynecologist.  Current Opinion in Obstet & Gynecol.  11:45-49, 1999.
  199. van Nagell, J.R., Jr.; DePriest, P.D.; Reedy, M.B.; Gallion, H.H.; Ueland, F.R.; Pavlik, E.J.; Kryscio, R.J.:  The Efficacy of Transvaginal Sonographic Screening in Asymptomatic Women at Risk for Ovarian Cancer.  Gynecol Oncol 77:350-356, 2000.
  200. Pavlik, E.J.; DePriest, P.D., Gallion, H.H.; Ueland, F.R.; Reedy, M.B.; Kryscio, R.J.; van Nagell, J.R., Jr.:   Ovarian Volume Related to Age.  Gynecol Oncol 77:410-412, 2000.
  201. Schilder, J.M.; Thompson, A.M.; DePriest, P.D.; Ueland, F.R.; Cibull, M.L.; Kryscio, R.J.; Modesitt, S.C.; Geisler, J.P.; Higgins, R.V.; Magtibay, P.M.; Cohn, D.E.; Powell, M.A.; Stehman, F.B; van Nagell, J.R.:  Outcome of Reproductive Age Women with Stage IA or IC Invasive Epithelial Ovarian Cancer Treated with Fertility-Sparing Surgery.  Gynecol Oncol 87:1-7, 2002.
  202. Modesitt, S.C.; Pavlik, E.J.; Ueland, F.R.; DePriest, P.D.; van Nagell, J.R., Jr.:  Risk of Malignancy in Unilocular Ovarian Cystic Tumors Less Than 10 cm in Diameter:  A Long-term Follow-up Study.  Obstet. Gynecol. 102:594-599, 2003.
  203. Ueland, F.R.; DePriest, P.D.; Pavlik, E.J.; Kryscio, R.J.; van Nagell, J.R.:  Preoperative Differentiation of Malignant from Benign Ovarian Tumors:  The Efficacy of Morphology Indexing and Doppler Flow Sonography.  Gynecol. Oncol. 91:46-50, 2003.
  204. Wilder, J.L.; Pavlik, E.J.; Straughn, J.M.; Higgins, R.V.; Kryscio, R.J.; Whitley, R.J.; van Nagell, J.R., Jr.:  Clinical Implications of a Rising Serum Ca-125 Within the Normal Range in Patient with Epithelial Ovarian Cancer.  Gynecol. Oncol. 89:233-235, 2003.
  205. Rushing, R.S.; Shajahan, S.; Chendil, D.; Wilder, J.; Pulliam, J.; Lee, E.; Ueland, F.; van Nagell, J.R.; Ahmed, M.; Lele, S.:  Uterine Sarcomas Express KIT Protein but Lack Mutation(s) in Exon 11 or 17 of c-KIT.  Gynecol. Oncol. 91:9-14, 2003.
  206. DeSimone, C.P.; Greenberg V.L.; Chobanian, N., van Nagell, J.R., Jr, Zimmer SG:  The Combined In Vitro Effect of Paclitaxel and Histone Deacetylase Inhibition on Ovarian Cancer.  Am. Assoc. for Ca. Res. 44:217, 2003.
  207. Wilder, J.L.; Shajahan, S.; Khattar, N.H.; Wilder, D.M.; Yin, J.; Rushing, R.S.; Beaven, R.; Kaetzel, C.; Ueland, F.R.; van Nagell, J.R., Jr.; Kryscio, R.J.; Lele, S.M.:  Tamoxifen-Associated Malignant Endometrial Tumors:  Pathologic Features and Expression of hormone Receptors Estrogen-(alpha), Extrogen-(beta) and Progesterone:  A Case Controlled Study.  Gynecol. Oncol. 92:553-558, 2004.
  208. Chobanian, N.; Greenberg, V.; Gass, J.; DeSimone, C.P.; van Nagell, J.R. ,Jr.; Zimmer, S.  Histone Deacetylase Inhibitors Enhance Paclitaxel-Induced Cell Death in Ovarian Cancer Cell Lines Independent of p53 Status.  Anticancer Research 24:539-546, 2004.
  209. van Nagell, Jr., J.R. and DePriest, P.D.:  Management of Adnexal Masses in Postmenopausal Women.  Am J Ob Gyn 193:30-35, 2005.
  210. Ueland, F.R.; DePriest, P.D.; Pavlik, E.J.; van Nagell Jr. J.R.:  The Accuracy of Examination Under Anesthesia and Transvaginal Sonography for Ovarian Measurement.  Gynecol Oncol 99:400-403, 2005. 
  211. Modesitt, S.C.; van Nagell, Jr., J.R.:  The Impact of Obesity on the Incidence and Treatment of Gynecologic Cancers:  A Review.  Ob Gyn Survey 60:683-692, 2005.
  212. Dietrich III C, Modesitt S, DePriest P, Ueland F, Wilder J, Reedy M, Kryscio R, van Nagell Jr JR, Giesler J, Manahan K, Huh W, Cohn D, Powell M, Slomovitz B, Higgins R, Merritt W, Hunter J, Puls L, Gehrig P:  The Efficacy of Adjuvant Platinum-based Chemotherapy in Stage I Uterine Papillary Serous Carcinoma (UPSC).  Gynecol. Oncol. 99:557-563, 2005.
  213. DeSimone, C.P.; Crisp, M.; Ueland, F.R.; DePriest, P.D.; van Nagell, Jr., J.R.; Lele, S.M.; Modesitt, S.C.:  Concordance of Gross Surgial Margins to Final Fixed Margins in Women with Vulvar Intraepithelial Neoplasia III and Vulvar Cancer.  J. Reprod. Med. 51:617-621, 2006.
  214. Dietrich, III, C.S., DeSimone, C.P., Modesitt, S.C., DePriest, P.D., Ueland, F.R., Cooper, A.L., Pavlik, E.J., Kryscio, R., Cibull, M., Huh, W., Partridge, E., Numnum, T.M., Schilder, J., Higgins, R.V., van Nagell, Jr., J.R.:  Primary Appendiceal Cancer:  Gynecologic Manifestations and Treatment Options.  Gynecol. Oncol. 104:602-606, 2007.
  215. van Nagell, Jr., J.R., DePriest, P.D., Ueland, F.R., DeSimone, C.D., Cooper, A.L., Pavlik, E.J., Kryscio, R.J.  Ovarian Cancer Screening with Annual Transvaginal Sonography:  Findings of 25,000 Women Screened.  Cancer 109:1887-1896, 2007.
  216. DeSimone, C.P.; Van Ness, J.S.; Cooper, A.L., Modesitt, S.C., DePriest, P.D., Ueland, F.R., Pavlik, E.J., Kryscio, R.J., van Nagell, Jr., J.R.:  The Treatment of Lateral T1 and T2 Squamous Cell Carcinomas of the Vulva Confined to the Labium Majus or Minus.  Gynecol. Oncol. 104:390-395, 2007. 
  217. van Nagell, Jr., J.R., DeSimone, C.P.  Treatment of Patients with Appendiceal and Peritoneal Dissemination.  Letter to the Editor (Invited).  Gynecol. Oncol. 107: 592-593, 2007.
  218. Cooper, A.; Nelson, D.; Doran, S.; Ueland, F.R.; DeSimone, C.P.; DePriest, P.D.; McDonald, J.; Saunders, B.; Ware, R.A.; Pavlik, E.J.; Kryscio, R.J.; Karpf, M; van Nagell, J.R., Jr.:  Long Term Survival and Cost of Treatment in Patients with Stage IIIC Epithelial Ovarian Cancer.  Current Women’s Health Reviews 5:44-50, 2009.
  219. Pavlik, E.J.; Saunders, B.A.; Doran, S.; McHugh, K.W.; Ueland, F.R.; DeSimone, C.P.; DePriest, P.D.; Ware, R.A.; Kryscio, R.J.; van Nagell, J.R.: The Search for Meaning---Symptoms and TVS Screening for Ovarian Cancer:  Predicting Malignancy. Cancer 115:3689-3698, 2009.
  220. McDonald, J.M.; Doran, S.; DeSimone, C.P.; DePriest, P.D.; Ueland, F.R.; Saunders, B.A.; Ware, R.A.; Goodrich, S.; Pavlik, E.J.; Kryscio, R.J.; van Nagell, J.R.:  Predicting Risk of Malignancy in Adnexal Masses.  Obstet Gynecol 115:687-694, 2010.
  221. Saunders, B.A.; Podzielinski, I; Ware, R.A.; Goodrich, S.; DeSimone, C.P.; Ueland, F.R.; Seamon, L.; Ubellacker, J.; Pavlik, E.J.; Kryscio, R.J.; van Nagell, Jr., J.R.:  Risk of Malignancy in Sonographically Confirmed Septated Cystic Ovarian Tumors.  Gynecol Oncol 118:278-282, 2010.
  222. Ware RA, van Nagell Jr JR:  Radical Hysterectomy - Indications, Technique, and Complications.  Obstetrics and Gynecology International Vol. 2010, Article ID 587610.
  223. DeSimone CP, Elder J, van Nagell JR Jr:  Selective Inguinal Lymphadenectomy in the Treatment of Invasive Squamous Cell Carcinoma of the Vulva.  Int. J. Surg Oncol. Vol. 2011, Article ID 284374.
  224. Miller RW, van Nagell Jr JR:  Preoperative Evaluation of Adnexal Masses.  Women’s Health 7:37-39, 2011.
  225. Ueland FR, Goodrich S, Desimone C, Seamon L, Miller R, Podzielinski I, Smith A, van Nagell Jr JR, Zhang Z:  Effectiveness of OVA1 in the preoperative assessment of ovarian tumors. Obstet Gynecol 117:1289-1297, 2011.
  226. Miller R, Smith A, Desimone C, Seamon L, Goodrich S, Podzielinski I, Sokoll L, van Nagell Jr JR, Zhang Z, Ueland F:  The American College of Obstetricians and Gynecologists ovarian tumor referral guidelines with OVA1.  Obstet Gynecol 117:1298-1306, 2011.
  227. van Nagell, J.R.; Miller, R.W.; DeSimone, C.P.; Ueland, F.R.; Podzielinski, I.; Goodrich, S.T., Elder, J.W., Huang, B.; Kryscio, R.J., Pavlik, E.J.:  Long-Term Survival of Women with Epithelial Ovarian Cancer Detected by Ultrasonographic Screening.  Obstet Gynecol 118:1212-1221, 2011.
  228. van Nagell, J.R.:  Early Detection of Ovarian Cancer in Symptomatic Women.  The Lancet Oncol 13(3): 223-224, 2012.
  229. Pavlik E.J., van Nagell, J.R.:  Ovarian Cancer Screening – What Women Want.  Int J Gynecol Cancer, Vol. 22, Number S1, 2012.
  230. van Nagell, J.R.; Pavlik, E.J.:  Ovarian Cancer Screening. Clin Obstet Gynecol 55:43-51, 2012.
  231. Baldwin, L.A., Huang, B, Biller R.W., Tucker, T., Goodrich, S.T., Podzielinski, Il, DeSimone, C.P., Ueland, F.R., van Nagell, J.R., Seamon, L.G. Ten-year Relative Survival for Epithelial Ovarian Cancer. Obstet Gynecol 2012 Sep;120(3):612-8.
  232. Pavlik, E.J., van Nagell, J.R.:  Early Detection of Ovarian Tumors Using Ultrasound.  Women’s Health 9(1):39-57, 2013.
  233. Podzielinski, I., Saunders, B., Kimbler, K., Branscum, A, Fung, E, DePriest, P., van Nagell, J.R., Ueland, F., Baron, A.  Apolipoprotein Concentrations are Elevated in Malignant Ovarian Cyst Fluids Suggesting that Lipoprotein Metabolism is Dysregulated in Epithelial Ovarian Cancer. Cancer Invest 31(4):258-72, 2013.
  234. Pavlik, E.J., Ueland, F.R., Miller, R.A., Ubellacker, J.M., DeSimone, C.P., Elder, J., Hoff, J., Baldwin, L., Kryscio, R.J., and van Nagell, J.R. Frequency and Disposition of Ovarian Abnormalities Followed with Serial Transvaginal Ultrasonography. Obstet Gynecol 2013; 122:210-7.
  235. Skaggs, H., Saunders, B., Ware, R,A., Goodrich, S.T., King, M. S., Kimbler, K.D., Branscum, A.J., Fung, E.T., DePriest, P.D., van Nagell, J.R, Ueland, F.R., and Baron, A.T.  Ovarian Cyst Fluids Are a Cache of Tumor Biomarkers That Include Calgranulin A and Calgranulin B Isoforms. Cancer Invest 31,7:433-53, 2013.
  236. van Nagell, J.R., and Hoff, J.T.  Transvaginal Ultrasonography in Ovarian Cancer Screening. Int J Women’s Health 6:25-33, 2013.
  237. Hoff, J.T., Baldwin, L.A., Lefringhouse, J, Pavlik, E.J., Miller, R.W., DeSimone, C.P., Ueland, F.R., Tucker, T.C., Kryscio, R.J., and van Nagell, J.R.  Survival Advantage Associated with Decrease in Stage at Detection from Stage IIIC to Stage IIIA Epithelial Ovarian Cancer.  J Oncol 2014, doi.org/10.1155/2014/312193.
  238. Elder, J, Pavlik, E, Long, A, Miller, R, DeSimone, C, Hoff, J, Ueland, W, Kryscio, R, van Nagell, J.R., and Ueland, F. Serial ultrasonographic evaluation of ovarian abnormalities with a morphology index.  Gynecol Oncol 135(1):8-12, 2014.
  239. Jia, C, Erfani, S, Liu, Z, Chen, Y, Lu, M, Huang, J, van Nagell, J.R., Kaetzel, D, Zhou, B, and Yang, X. Emerging links of CD151 and integrins to tumoigenesis and EMT induction in ovarian cancer.  Cancer Cell & Microenviron 2015: 2:e670.doi:10.14800/ccm.670.
  240. Ormsby, E, Pavlik, E, and van Nagell, J.R. Ultrasound Follow Up of an Adnexal Mass has the Potential to Save Lives.  Am J Ob Gyn 2015, doi:10.1016/ajog.2015.06.041.

Chapters

  1. van Nagell, J.R., Jr.:  Urinary Tract Complications in Pregnancy.  Davis' Gynecology and Obstetrics.  Harper and Row Publishers, Inc.  Vol. 1, Chapter 66, 1972.
  2. van Nagell, J.R., Jr. and Gay, E.C.:  Vaginal Cancer.  Chapter in Modern Concepts of Gynecologic Oncology.  van Nagell, J.R. and Barber, H.R. (Eds.) John Wright Publishers, Boston, Mass., 1982.
  3. van Nagell, J.R., Jr. and Powell, D.F.:  Cervical Intraepithelial Neoplasia.  Chapter in Modern Concepts of Gynecologic Oncology.  van Nagell, J.R. and Barber, H.R. (Eds.) John Wright Publishers, Boston, Mass., 1982.
  4. van Nagell, J.R., Jr.; Gay, E.C.; and Powell, D.F.:  Invasive Cancer of the Cervix.  Chapter in Modern Concepts of Gynecologic Oncology.  van Nagell, J.R. and Barber, H.R. (Eds.) John Wright Publishers, Boston, Mass., 1982.
  5. Maruyama, Y. and van Nagell, J.R., Jr.:  Radiation Therapy in Cervical Cancer.  Chapter in Modern Concepts of Gynecologic Oncology.  van Nagell, J.R. and Barber, H.R. (Eds.) John Wright Publishers, Boston, Mass., 1982.
  6. van Nagell, J.R., Jr.; Powell, D.F.; and Pavlik, E.J.:  Biochemical Markers in Gynecologic Cancer.  Chapter in Modern Concepts of Gynecologic Oncology.  van Nagell, J.R. and Barber, H.R. (Eds.) John Wright Publishers, Boston, Mass., 1982.
  7. van Nagell, J.R., Jr.:  Tumor Markers in Gynecologic Malignancies.  Cancer Research and Treatment.  Gynecological Malignancy I.  C.T. Griffiths, (Ed.) Martinus Nijhoff, Amsterdam, 1982.
  8. van Nagell, J.R., Jr.:  Cervical Cancer.  Surgical Oncology.  Pilch and DasGuptas, (Eds.)  W.B. Saunders, Philadelphia, Penn., 1982.
  9. van Nagell, J.R., Jr.; Donaldson, E.S.; and Gay, E.C.:  Urinary Tract Involvement by Invasive Cervical Cancer.  Chapter 27 in Gynecologic and Obstetric Urology.  Buchsbaum and Schmidt (Eds.)  W.B. Saunders, Philadelphia, Penn., 1982.
  10. van Nagell, J.R., Jr.; Donaldson, E.S.; and Hanson, M.B.:  Evaluation and Therapy of Cervical Cancer.  Current Problems in Cancer, Yearbook Pub.  Vol. 8, No. 5, 1983.
  11. van Nagell, J.R., Jr. and Higgins, R.V.:  Invasive Cancer of the Cervix:  Clinical Features and Pretreatment Evaluation.  Chapter 40 in Gynecologic Oncology.  Coppleson (Ed.)  Churchill Livingstone Publishers, London, England, 1989.
  12. van Nagell, J.R., Jr.; Higgins, R.V.; and Donaldson, E.S.:  Urinary Tract Involvement by Invasive Cervical Cancer.  Chapter 27 in Gynecologic and Obstetric Urology.  Buchsbaum (Ed.)  W.B. Saunders Company, Philadelphia, Pennsylvania, 1989.
  13. DePriest, P.D.; van Nagell, J.R., Jr.; and Powell, D.E.:  Microinvasive Cervical Cancer.  Chapter in Clinical Obstetrics and Gynecology.  Jones, H.W. (Ed.)  J.B. Lippincott Company, Lippcot, Philadelphia, Pennsylvania, 1990.
  14. van Nagell, J.R., Jr.; Higgins, R.V.; and Powell, D.E.:  Invasive Cervical Cancer.  Chapter in Gynecologic Oncology.  Knapp, R.C. and Berkowitz, R. (Eds.)  2nd Edition.  Pergamon Press, Inc., Elmsford, New York, 1992.  
  15. DePriest, P.D. and van Nagell, J.R., Jr.:  Transvaginal Ultrasound Screening for Ovarian Cancer.  Chapter in Clinical Obstetrics and Gynecology.  Podratz, K.C. (Ed.)  J.B. Lippincott Company, Philadelphia, Pennsylvania, 1992.
  16. DePriest, P.D. and van Nagell, J.R., Jr.:  Woman With Abdominal Distention.  Chapter in Selected Case Studies in Laboratory Medicine.  Tietz, N.W. (Ed.)  W.B. Saunders Company, Orlando, Florida, 1992. 
  17. van Nagell, J.R., Jr. and DePriest, P.D.:  Early Diagnosis of Epithelial Ovarian Cancer.  Chapter in Ovarian Cancer.  Markman, M. and Hoskins, W. (Eds.)  Raven Press, New York, New York, 1993. 
  18. van Nagell, J.R., Jr.; DePriest, P.D.; Higgins, R.V.; and Powell, D.E.:  Surgical Therapy of Cervical Cancer.  Chapter in Operative Gynecology.  Gershenson, D.M., DeCherney, A.H. and Curry, S.L. (Eds.)  W.B. Saunders Company, Philadelphia, Pennsylvania, 1993.
  19. van Nagell, J.R., Jr. and DePriest, P.D.:  Early Diagnosis of Epithelial Ovarian Cancer.  Chapter in Principles and Practice of Gynecologic Oncology.  Hoskins, W., Perez, C.A., and Young, R.C. (Eds.)  Lippincott Healthcare Publications, Philadelphia, PA, 1993.
  20. van Nagell, J.R., Jr.:  Ovarian Carcinoma with Transvaginal Sonography.  Chapter in Early Detection of Ovarian Carcinoma with Transvaginal Sonography.  Fleischer, A.C. and Jones, H.W. (Eds.).  Raven Press, New York, New York, 1993. 
  21. DePriest, P.D.; Gallion, H.H.; and van Nagell, J.R., Jr.:  Transvaginal Ultrasound as a Screening Method for Ovarian Cancer.  Chapter in When to Screen in Obstetrics and Gynecology.  Wildschut, H.I., Weiner, C.P., and Peters, T.J. (Eds.)  W.B. Saunders, Philadelphia, Pennsylvania, 1996.
  22. van Nagell, J.R., Jr. and DePriest, P.D.:  Gynecologic Cancer Screening.  Chapter in Gynecologic Oncology:  Current Diagnosis and Treatment.  Fowler, W.C. and Shingleton, H.M. (Eds.)  W.B. Saunders, Philadelphia, Pennsylvania, 1996.
  23. DePriest, P.D. and van Nagell, J.R., Jr.:  Screening for Epithelial Ovarian Cancer.  Chapter in Controversies in the Management of Ovarian Cancer.  Gershenson, D.M. and McGuire, W.P. (Eds.)  Churchill Livingstone, New York, New York, 1995. 
  24. van Nagell, J.R., Jr. and DePriest, P.D.:  Ovarian Cancer:  Etiology, Screening, and Surgery.  Chapter in Operative Gynecology.  Rock, J.A. and Jones, H.A. (Eds.)  Lippincott, Williams and Wilkins, Philadelphia, Pennsylvania, 2003.
  25. DePriest, P.D.; Gallion, H.H.; and van Nagell, J.R., Jr.:  Transvaginal Ultrasound as a Screening Method for Ovarian Cancer.  Chapter in When to Screen in Obstetrics and Gynecology.  Wildschut, H.I., Weiner, C.P., and Peters, T.J. (Eds.)  W.B. Saunders, Philadelphia, Pennsylvania, 2nd Edition.  2004.
  26. Ueland, F.R.; DePriest, P.D.; and van Nagell, J.R., Jr.:  Management of Cystic Ovarian Tumors in the Perimenopausal Woman.  Chapter in   Management of the Perimenopause (Practical Pathways in Obstetrics and Gynecology series).  Liu, James and Gass, Margery (Eds.):  McGraw-Hill.  2006.
  27. van Nagell, J.R., Jr. and Gershenson D.M.:  Ovarian Cancer:  Etiology, Screening, and Surgery.  Chapter in TeLindes’s Operative Gynecology.  Rock, J.A. and Jones, H.A. (Eds.)  Lippincott, Williams and Wilkins, Philadelphia, Pennsylvania, 10th Edition.  2008.

Books

  1. van Nagell, J.R., Jr. and Barber, H.R.K. (Eds.):  Modern Concepts of Gynecologic Oncology.  John Wright Publishers, Boston, Mass., 1982.
  2. Ueland, F.R.; Modesitt, S.; DePriest, P.D. and van Nagell J.R., Jr.:  Chemotherapeutics in Gynecologic Oncology.  (In Press)

 

JOHN RENSSELAER VAN NAGELL, MD

Professor of Obstetrics and Gynecology
University of Kentucky
USA